BIGNAMINI, ELISA
BIGNAMINI, ELISA
Universita' degli Studi di MILANO
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
2021 P.A. Flume, R.F. Biner, D.G. Downey, C. Brown, M. Jain, R. Fischer, K. De Boeck, G.S. Sawicki, P. Chang, H. Paz-Diaz, J.L. Rubin, Y. Yang, X. Hu, D.J. Pasta, S.J. Millar, D. Campbell, X. Wang, N. Ahluwalia, C.A. Owen, C.E. Wainwright, R.L. Gibson, S.M. Rowe, N. Lechtzin, R.C. Ahrens, K.S. Mccoy, M. Aitken, S.H. Donaldson, K.A. Mcbennett, J.M. Pilewski, J. Billings, C. Milla, R. Rubenstein, D.B. Rosenbluth, R. Linnemann, M.R. Powers, C. Fortner, C.A. Frederick, T.G. Liou, P. Black, J. Wang, J.L. Colombo, M. Berdella, M.V. Indihar, C.D. Brown, M. Anstead, L. Bilodeau, L. Sicilian, J.J. Tolle, K. Moffett, S. Nasr, J. Taylor-Cousar, T.L. Barto, N. Antos, J.S. Rogers, B. Quick, H.R. Thompson, G. Sawicki, B. Barnett, R.L. Zanni, T.C. Smith, K.D. Schultz, C. Keating, P. Flume, G.J. Omlor, A. Ashare, K. Voter, N. Mehdi, M.G.T. Ortiz, T.E. Gardner, S.R. Boas, B. Messore, E. Zemanick, R. Jain, M. Mccarthy, D.G. Kissner, K. Patel, J. Mcnamara, J. Philley, A. Berlinski, F.J. Calimano, T. Chin, D. Conrad, C. Daines, H.H. Raissy, T.G. Keens, J.E. Lascano, B. Mcwilliams, B. Morrissey, S. Reyes, S. Chittivelu, S. Hussain, A. Stone, J. Wallace, R. Klingsberg, J.A. Biller, S. Bui, O. Sommerburg, E. Bignamini, M. Collura, A. Moller, D. Salvatore, C. Belleguic, L. Bentur, O. Efrati, E. Kerem, D. Prais, E.Q. Gallego, P. Barry, G. Livnat-Levanon, J.R.V. Asensi, D.S. Armstrong, O.A. de la Cruz, F. Gilchrist, D.E. Tullis, B. Quon, L.C. Lands, N. Morrison, A. Lavoie, B. Linnane, O. Elidemir, F. Ringshausen, M. Kappler, H. Hebestreit, J. Mainz, A. Kiefer, C. Koerner-Rettberg, D. Staab, W. Gleiber, T. Pressler, F. Stehling, A. Hector, S. Sutharsan, L. Naehrlich, J.C. Davies, R.I. Ketchell, M.P. Carroll, S. Doe, G. Macgregor, E.F. Nash, N. Withers, D.G. Peckham, M.J. Ledson, S. Kansra, T.W.R. Lee, B. Delaisi, G. Rault, J. Le Bihan, D. Hubert, I. Fajac, I. Sermet-Gaudelus, M. Bakker, B. Arets, C. De Boeck, R. Chiron, P. Reix, C. Mainguy, E. van Braeckel, A. Malfroot, I. Durieu, N.D. Dufeu, A. Prevotat, R. van der Meer, P. Merkus, E.J.M. Weersink, I.B. Gomez-Aguero, S. Gartner, A.S. Jover, A.A. Fernandez, D.W. Cox, E.F. Mckone, B.J. Plant, H. Selvadurai, S.D. Bowler, C.E. Wainwright, D. Smith, P.G. Middleton, J.W. Wilson, S. Volpi, C. Colombo, B. Fabrizzi, V. Lucidi, F. Cresta, S. Cucchiara, E. Eber, H. Ellemunter, I. Huttegger, L. Hjelte, C. Krantz, M. Gilljam
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
2021 C. Colombo, G. Alicandro, V. Dacco, V. Gagliano, L.C. Morlacchi, R. Casciaro, G. Pisi, M. Francalanci, R. Badolato, E. Bignamini, B. Messore, M.C. Lucanto, G. Leonetti, M. Maschio, M. Cipolli
Tubercolosi sternale : una rara presentazione di malattia tubercolare
2006 V. Vincenti, F. Minonzio, C. Hu, G. Fabio, S. Colombo, A. Bianchi, E. Bignamini, M. Ferrarese, M.D. Cappellini
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study | 1-lug-2021 | Yang Y.Hu X.Bignamini E.Salvatore D.Colombo C. + | Article (author) | - | |
| SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020 | 13-mag-2021 | Colombo C.Alicandro G.Morlacchi L. C.Francalanci M.Bignamini E.Leonetti G.Maschio M. + | Article (author) | - | |
| Tubercolosi sternale : una rara presentazione di malattia tubercolare | 1-gen-2006 | V. VincentiG. FabioS. ColomboA. BianchiBIGNAMINI, ELISAM.D. Cappellini + | Article (author) | - |